Skip to content
Subscriber Only
Business
Prognosis

China Sinovac Shot Seen Highly Effective in Real World Study

  • Indonesia health workers 96% protected against hospitalization
  • Developing countries can’t vaccinate populations fast enough
Video player cover image
WATCH: Sinovac Biotech CEO Yin Weidong discusses CoronaVac's efficacy rate, exportation of the vaccine, and new findings on how it works against variants.(Source: Bloomberg)
Updated on

Sinovac Biotech Ltd.’s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical trials.

Indonesia tracked 128,290 health workers in capital city Jakarta from January to March and found that the vaccine protected 98% of them from death and 96% from hospitalization as soon as seven days after the second dose, Pandji Dhewantara, a Health Ministry official who oversaw the study, said in a Wednesday press conference.